REX American Resources Corp
Energy
REX American Resources Corp (REX) Stock News
The latest REX headlines and market coverage — 3 recent stories, updated throughout the day.
- GlobeNewswire Inc.·
QTREX Establishes U.S. Subsidiary to Advance Federal Government Contracting
QTREX Quantum Ltd. announced the formation of QTREX USA, a new U.S. subsidiary designed to support federal government contracting and defense procurement activities. The move follows the company's operational AME deployment at a U.S. government laboratory and aims to address national security requirements including FOCI, ITAR compliance, and Buy American Act considerations while establishing domestic manufacturing capabilities.
- GlobeNewswire Inc.·
Recludix Pharma to Present Preclinical Asthma and Dermatitis Data for Oral STAT6 Inhibitor REX-8756 at the European Association of Allergy and Clinical Immunology (EAACI) and Revolutionizing Atopic Dermatitis (RAD) Congresses
Recludix Pharma announced preclinical data for REX-8756, an oral STAT6 inhibitor, demonstrating efficacy comparable to anti-IL-4/IL-13 antibody therapies in asthma and dermatitis models with a differentiated safety profile. The compound will be presented at EAACI and RAD congresses in June 2026. REX-8756 is currently in Phase 1 clinical trials under a partnership with Sanofi.
- Benzinga·
What's Going On With QTREX Quantum Stock Monday?
QTREX Quantum (NASDAQ: QTEX) surged over 19% in premarket trading on Monday, driven by broader market momentum in speculative growth stocks and a new purchase order from a Fortune 500 company for its additively manufactured electronics (AME) system. The stock, which has gained 262.8% over the past 12 months, remains volatile with traders watching key technical levels around $1.50-$1.70 and potential resistance at $2.00.